26
|
Breillat P, Mathian A, Hie M, Pineton De Chambrun M, Miyara M, Cohen Aubart F, Boutolleau D, Pha M, Calvez V, Haroche J, Rozenberg F, Burrel S, Amoura Z. La réplication du virus Epstein-Barr est fréquente lors des poussées de lupus systémique. Rev Med Interne 2019. [DOI: 10.1016/j.revmed.2019.10.097] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
27
|
Bonnet P, Moguelet P, Abisror N, Itzykson R, Bouaziz JD, Hirsch P, Barbaud A, Haroche J, Mekinian A, Hélias-Rodzewicz Z, Clappier E, Fenaux P, Fain O, Tazi A, Emile JF, Chasset F. Identification de mutations clonales identiques dans les xanthélasma palpébraux de maladie d’Erdheim-Chester associés à des leucémies myélomonocytaires chroniques: à propos de 3 cas. Ann Dermatol Venereol 2019. [DOI: 10.1016/j.annder.2019.09.146] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
28
|
Chazal T, Costopoulos M, Maillart E, Fleury C, Psimaras D, Legendre P, Pineton de Chambrun M, Haroche J, Lubetzki C, Amoura Z, Legarff-Tavernier M, Cohen Aubart F. The cerebrospinal fluid CD4/CD8 ratio and interleukin-6 and -10 levels in neurosarcoidosis: a multicenter, pragmatic, comparative study. Eur J Neurol 2019; 26:1274-1280. [PMID: 31021023 DOI: 10.1111/ene.13975] [Citation(s) in RCA: 26] [Impact Index Per Article: 5.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/16/2018] [Accepted: 04/23/2019] [Indexed: 12/11/2022]
Abstract
BACKGROUND AND PURPOSE Neurosarcoidosis is a rare inflammatory disorder of unknown cause. The aim of this study was to evaluate the value of T/B lymphocyte population counts and the concentrations of the cytokines interleukin (IL) 6 and IL-10 in the cerebrospinal fluid (CSF) of neurosarcoidosis patients. METHODS A retrospective study CSF biomarkers was conducted in patients with neurosarcoidosis who underwent CSF analysis between 2012 and 2017 as well as various control populations. RESULTS Forty-three patients with neurosarcoidosis, 14 with multiple sclerosis (MS) and 48 with other inflammatory disorders were analyzed. The CSF IL-6 levels were higher in sarcoidosis patients than in MS patients (median 8 vs. 3 pg/ml, P = 0.006). The CSF CD4/CD8 ratio was higher in sarcoidosis patients than in MS patients and in patients with other inflammatory disorders (median 3.18 vs. 2.36 and 2.10, respectively, P = 0.008). The CSF IL-6 level was higher in patients with active neurosarcoidosis than in non-active neurosarcoidosis patients (median 13 vs. 3 pg/ml, P = 0.0005). In patients with neurosarcoidosis, a CSF IL-6 concentration >50 pg/ml was associated with a higher risk of relapse or progression-free survival (hazard ratio 3.60; 95% confidence interval 1.78-23.14). A refractory neurosarcoidosis patient was treated with an anti-IL-6 monoclonal antibody that produced a complete neurological response. CONCLUSIONS The CSF CD4/CD8 ratio and IL-6 concentration are increased in neurosarcoidosis compared to MS and other inflammatory disorders. A CSF IL-6 concentration >50 pg/ml is associated with relapse or progression of neurosarcoidosis. IL-10 levels may be elevated in neurosarcoidosis.
Collapse
|
29
|
Morel N, Mehawej H, Bonnet C, Le Guern V, Perard L, Roumier M, Brézin A, Godeau B, Haroche J, Piette J, Costedoat-Chalumeau N. Syndrome catastrophique des antiphospholipides et atteinte du segment postérieur de l’œil. Rev Med Interne 2019. [DOI: 10.1016/j.revmed.2019.03.013] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
30
|
Haroche J, Azoulay L, Cohen-Aubart F, Emile J, Cluzel P, Amoura Z, Bravetti M. La présence d’une mutation BRAFV600E est associée à une atteinte cardiaque dépistée par imagerie dédiée chez 205 patients ayant une maladie d’Erdheim–Chester. Rev Med Interne 2019. [DOI: 10.1016/j.revmed.2019.03.061] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
31
|
Pha M, Mathian A, Haroche J, Hie M, Cohen Aubart F, Boutin D, Chérin P, Devilliers H, Amoura Z. L’arrêt des corticoïdes à faible dose (5 mg) augmente le risque de rechute au cours du lupus systémique en rémission depuis au moins un an : résultats de l’étude randomisée CORTICOLUP. Rev Med Interne 2019. [DOI: 10.1016/j.revmed.2019.03.031] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
32
|
Mestiri R, Pineton De Chambrun M, Augustin J, Mathian A, Hie M, Pha M, Cohen Aubart F, Charlotte F, Haroche J, Boutin D, Brocheriou I, Amoura Z. Hépatites auto-immunes au cours du lupus systémique : étude rétrospective et revue de la littérature. Rev Med Interne 2019. [DOI: 10.1016/j.revmed.2019.03.073] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
33
|
Mouries-Martin S, Mathian A, Devilliers H, Dorgham K, Cohen Aubart F, Haroche J, Hie M, Pineton De Chambrun M, Miyara M, Pha M, Gorochov G, Amoura Z. La mesure directe du taux d’Interferon alpha sérique par un nouvel ELISA digital chez les malades en rémission est prédictif du risque de poussée lupique dans l’année. Rev Med Interne 2019. [DOI: 10.1016/j.revmed.2019.03.030] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
34
|
Liberatore J, Landron C, Roblot P, Allouchery M, Haroche J, Martin M. Erdheim Chester, quand les anticorps s’en mêlent. Rev Med Interne 2019. [DOI: 10.1016/j.revmed.2019.03.235] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
35
|
Chazal T, Lhote R, Haroche J, Mathian A, Hie M, Pha M, Amoura Z, Cohen Aubart F. Développement et validation d’un score d’activité dans la sarcoïdose : le Sarcoidosis disease activity index (SDAI). Rev Med Interne 2019. [DOI: 10.1016/j.revmed.2019.03.014] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
36
|
Amoura A, Haroche J, Emile J, Barete S, Helias‐Rodzewicz Z, Charlotte F, Maisonobe T, Amoura Z, Cohen Aubart F. Sarcoidosis occurring during
BRAF
/
MEK
inhibitors is associated with paradoxical
ERK
activation in Erdheim‐Chester patients. J Eur Acad Dermatol Venereol 2019; 33:e348-e350. [DOI: 10.1111/jdv.15636] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
37
|
Gutierrez B, Grados A, Palat S, Ribeiro E, Ruivard M, Le Gouellec N, Haroche J, Papo T, Harlé J, Ly K, Schleinitz N, Ebbo M. Évènements thrombotiques artériels et veineux au cours de la maladie associée aux IgG4 : étude rétrospective à partir des données de la cohorte nationale française. Rev Med Interne 2018. [DOI: 10.1016/j.revmed.2018.10.328] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
38
|
Lhote R, Nunes H, Sacré K, Launay D, Mahevas M, Haroche J, Chazal T, Devilliers H, Amoura Z, Annesi-Maesano I, Cohen Aubart F. Éfficacité et tolérance du rituximab dans la sarcoïdose : étude multicentrique de 11 patients et revue de 27 cas de la littérature. Rev Med Interne 2018. [DOI: 10.1016/j.revmed.2018.10.334] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
39
|
Razanamahery J, Humbert S, Emile J, Méaux-Ruault N, Gil H, Haroche J, Magy-Bertrand N. Une maladie d’Erdheim-Chester révélée par des sténoses artérielles multiples. Rev Med Interne 2018. [DOI: 10.1016/j.revmed.2018.10.107] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
40
|
Mouries-Martin S, Mathian A, Devilliers H, Cohen Aubart F, Hie M, Haroche J, Pha M, Huong DBLT, Pineton De Chambrun M, Chérin P, Miyara M, Dorgham K, Gorochov G, Rozenberg F, Amoura Z. Surveillance biologique au cours du Lupus Systémique : le dosage sérique d’interféron alpha chez les malades en rémission est prédictif du risque de poussée lupique dans l’année. Rev Med Interne 2018. [DOI: 10.1016/j.revmed.2018.10.313] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
41
|
Urbain F, Le Goff W, Cohen Aubart F, Haroche J, Mathian A, Pha M, Hie M, Lhomme M, Ichou F, Ponnaiah M, Amoura Z. Profil métabolomique et lipidomique chez les patients lupiques : corrélation à l’activité de la maladie et au risque cardiovasculaire. Rev Med Interne 2018. [DOI: 10.1016/j.revmed.2018.10.266] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
42
|
Riehl D, Cohen Aubart F, Haroche J, Pha M, Pineton De Chambrun M, Hie M, Mathian A, Amoura Z. Atteintes neurologiques au cours du lupus systémique : nouveaux concepts à partir d’une cohorte monocentrique. Rev Med Interne 2018. [DOI: 10.1016/j.revmed.2018.03.340] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
43
|
Pha M, Mathian A, Haroche J, Cohen Aubart F, Hie M, Pineton De Chambrun M, Boutin D, Amoura Z. Lupus systémique à début pédiatrique : devenir à l’âge adulte. Rev Med Interne 2018. [DOI: 10.1016/j.revmed.2018.03.356] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
44
|
Cohen Aubart F, Haroche J, Emile JF, Charlotte F, Barete S, Schleinitz N, Donadieu J, Amoura Z. [Rosai-Dorfman disease: Diagnosis and therapeutic challenges]. Rev Med Interne 2018; 39:635-640. [PMID: 29501513 DOI: 10.1016/j.revmed.2018.02.011] [Citation(s) in RCA: 12] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/29/2017] [Revised: 01/28/2018] [Accepted: 02/04/2018] [Indexed: 12/24/2022]
Abstract
Rosai-Dorfman disease (RDD) was first described by the French pathologist Paul Destombes in 1965. It frequently affects children or young adults and is characterized by the presence of large histiocytes with emperipolesis. More than 50 years after this first description, the pathogenesis of this rare disease is still poorly understood. The revised classification of histiocytoses published in 2016 identified various forms of RDD, from familial RDD to IgG4-associated RDD. Almost 90% of the patients with RDD have cervical lymph nodes involvement although all the organs may virtually be involved. Outcomes are typically favorable. Treatments may be necessary in case of compression or obstruction, and are not well codified. The main therapeutic strategies rely on surgery, radiotherapy, steroids, immunosuppressive drugs or interferon-alpha and cladribine.
Collapse
|
45
|
Chasset F, Haroche J. Cutaneous manifestations of paediatric Erdheim–Chester disease, a histiocytosis of the ‘L’ group. Br J Dermatol 2018; 178:31-32. [DOI: 10.1111/bjd.15860] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/07/2023]
|
46
|
Lhote R, Annesi-Maesano I, Cohen-Aubart F, Nunes H, Launay D, Hamidou M, Borie R, Sacre K, Mahevas M, Schleinitz N, Haroche J, Papo T, Amoura Z, Valeyre D. EpiSarc : étude phénotypique des atteintes extrapulmonaires au cours de la sarcoïdose. Rev Mal Respir 2018. [DOI: 10.1016/j.rmr.2017.10.045] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
47
|
Jachiet V, Pha M, Haroche J, Pottier C, Psimaras D, Amoura Z, Cohen Aubart F. Atteintes vasculaires cérébrales au cours de la sarcoïdose : messages à partir d’une analyse de 39 cas. Rev Med Interne 2017. [DOI: 10.1016/j.revmed.2017.10.305] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
48
|
Chiron A, Mathian A, Charuel J, Sterlin D, Ghillani-Dalbin P, Haroche J, Gorochov G, Musset L, Amoura Z, Miyara M. Lupus systémique avec anticorps anti-DFS70. Rev Med Interne 2017. [DOI: 10.1016/j.revmed.2017.10.369] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
49
|
Cohen Aubart F, Le Garff-Tavernier M, Costopoulos M, Maillart E, Psimaras D, Pottier C, Chazal T, Lhote R, Legendre P, Pha M, Haroche J, Amoura Z. Biomarqueurs du liquide cérébro-rachidien au cours des neurosarcoïdoses : apports diagnostiques et pronostiques. Rev Med Interne 2017. [DOI: 10.1016/j.revmed.2017.10.307] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
50
|
Marchal A, Charlotte F, Maksud P, Haroche J, Lifferman F, Miyara M, Choquet S, Amoura Z, Cohen Aubart F. [Sarcoidosis flare after autologous stem cell transplantation: An immune paradox?]. Rev Med Interne 2017; 38:619-622. [PMID: 28196699 DOI: 10.1016/j.revmed.2017.01.001] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/07/2016] [Revised: 11/06/2016] [Accepted: 01/05/2017] [Indexed: 10/20/2022]
Abstract
INTRODUCTION Sarcoidosis is a systemic granulomatous disorder of unknown cause. Apparition or flare of previously diagnosed sarcoidosis following hematopoietic stem cell transplantation (HSCT) has rarely been reported. OBSERVATION We report a 62-year-old woman who presented a radiological flare of sarcoidosis post-autologous stem cell transplantation for a POEMS syndrome. Imaging findings and lymph node histology, which revealed non-caseating granuloma, were consistent with the sarcoidosis diagnosis. The patient was asymptomatic and was kept free of treatment. CONCLUSION Sarcoidosis must be considered ahead of compatible clinicoradiological presentation occurring after HSCT. Sarcoidosis can mimic metastatic cancer or lymphatic relapse. Tissue biopsies and exclusion of differential diagnosis of granuloma diseases are warranted to confirm sarcoidosis diagnosis.
Collapse
|